Waverley Pharma (TSXV:WAVE) Total Liabilities : C$2.24 Mil (As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Waverley Pharma Total Liabilities?

Waverley Pharma's Total Liabilities for the quarter that ended in Mar. 2024 was C$2.24 Mil.

Waverley Pharma's quarterly Total Liabilities increased from Sep. 2023 (C$1.85 Mil) to Dec. 2023 (C$2.09 Mil) and increased from Dec. 2023 (C$2.09 Mil) to Mar. 2024 (C$2.24 Mil).

Waverley Pharma's annual Total Liabilities declined from Dec. 2021 (C$1.90 Mil) to Dec. 2022 (C$1.60 Mil) but then increased from Dec. 2022 (C$1.60 Mil) to Dec. 2023 (C$2.09 Mil).

Waverley Pharma Total Liabilities Historical Data

The historical data trend for Waverley Pharma's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Waverley Pharma Total Liabilities Chart

Waverley Pharma Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

1.55

1.45

1.90

1.60

2.09

Waverley Pharma Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															1.75	1.71	1.85	2.09	2.24

Waverley Pharma Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Waverley Pharma's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.089	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.09

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	0.952	-	-1.137
	=	2.09

Waverley Pharma's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	2.238	+	(0	+	0
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	2.24

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	0.838	-	-1.4
	=	2.24

Waverley Pharma Total Liabilities Related Terms

Thank you for viewing the detailed overview of Waverley Pharma's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Waverley Pharma (TSXV:WAVE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Waverley Pharma Inc (TSXV:WAVE) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

5GZ:Germany

Address

1250 Waverley Street, Suite 4, Winnipeg, MB, CAN, R3T 6C6

Website

https://www.waverleypharma.com

Waverley Pharma Inc is a biopharmaceutical company. It is engaged in the research, development, and commercialization of human therapeutics that focuses on oncology. The company products pipeline includes Capecitabine and Temozolomide, among others.

Executives

Albert David Friesen

10% Security Holder, Director, Senior Officer